EU Food Supplement Regulations: A Compliance Primer for Brands

EU food supplement law is not impossibly complex, but it is layered. The rules are set at EU level, enforced country by country, and updated continuously through EFSA opinions and Commission implementing regulations. This guide is a plain-English compliance primer for supplement brand operators selling in Europe in 2026. It is not legal advice, for novel ingredients, contested claims, or borderline products, get a regulatory consultant.

The framework

Five EU-level instruments do most of the work:

• Directive 2002/46/EC, the food supplements directive. Defines what a food supplement is, lists permitted vitamins and minerals and their authorised forms (Annexes I and II), and frames purity and labelling.
• Regulation 178/2002, general food law. Establishes the Food Business Operator (FBO) concept, traceability obligations, and the obligation to place only safe food on the market.
• Regulation 1169/2011, food information to consumers. Mandatory label content, nutrition declaration, allergen flagging, font sizes, and language requirements.
• Regulation 1924/2006, nutrition and health claims. Only EFSA-authorised claims may appear, in the authorised wording, subject to nutrient thresholds and conditions of use.
• Regulation 2015/2283, novel foods. Any ingredient not consumed significantly in the EU before 15 May 1997 requires authorisation before sale. The EU Novel Food Catalogue is the working reference.

Plus the food contact materials regulation (1935/2004) for packaging, the contaminants regulation (1881/2006) for heavy metals and PAHs, the food hygiene package (852/2004 and 853/2004) for GMP, and a growing list of category-specific rules (caffeine warnings, plant substance restrictions, melatonin national thresholds).

EFSA in plain terms

EFSA (European Food Safety Authority) is the EU scientific body. It does not authorise products, it produces scientific opinions on safety and on claim substantiation, which the European Commission then converts into binding regulations. Two things to know:

• EFSA opinions on novel foods take 12–24 months on average. Plan around that.
• EFSA's rejection of a health claim is binding. A "not authorised" claim is illegal to use on the label, in marketing copy, on the website, and in influencer content tagged to your brand.

Novel foods, in 2026 reality

Novel food status is the rule most often violated by new brands. The Novel Food Catalogue (maintained by the Commission) lists ingredient assessments. As of mid-2026, examples of restricted or pending status:

• NMN, novel food, not authorised. Some national authorities actively enforce; products are at risk.
• CBD isolates and extracts, novel food, applications pending. Status unstable.
• Some mushroom extracts, depends on species, part used, and extraction. Lion's mane fruiting body is generally fine; mycelium grown on grain is contested.
• Synthetic urolithin A, spermidine, recent authorisations exist for specific producers and specific use levels. Generic versions remain restricted.

Check the catalogue entry for every ingredient before formulating. "A competitor sells it" is not a legal defence.

Authorised health claims

The EU Register lists every authorised claim, the substance it applies to, the exact wording, and the conditions of use. The discipline is:

1. Find the substance in the Register.
2. Confirm the product meets the condition (usually a minimum % NRV per serving for vitamins and minerals, or a minimum daily dose for other substances).
3. Use the authorised wording, or a wording "with the same meaning for the consumer", Commission and national authorities are strict on this.
4. Do not pair the claim with a disease prevention or treatment statement. That moves the product into medicinal product territory and is illegal as a food supplement.

Botanical health claims sit in a parallel queue (the "on-hold list") that has been on hold for over a decade. National enforcement varies; treat botanical claims as country-specific.

Labelling essentials under 1169/2011

• Name of the food, must include "food supplement" or the equivalent in the destination language.
• Ingredient list, descending order of weight, with the allergen list bolded or otherwise emphasised.
• Net quantity, in mass or volume per the format.
• Minimum durability date, "best before" with day/month/year.
• FBO name and EU address.
• Country of origin where required.
• Instructions for use and a warning not to exceed the daily dose.
• A statement that supplements are not a substitute for a varied diet and a keep-out-of-reach-of-children warning.
• Nutrition declaration per portion and per % NRV where applicable.
• Language, the label must be in the official language(s) of the destination market.

Country notification, the messy part

Most member states require pre-market notification to the national authority. Notification is administrative, not authorisation, you submit the dossier, you get an acknowledgement, you can sell. But the dossier has to be right or the product gets pulled.

• Italy, notification via the Ministero della Salute portal. Acknowledgement and listing in the national database, usually 4–8 weeks.
• France, Téléicare notification to DGCCRF, with specific scrutiny on plant substances under Décret "Plantes".
• Belgium, notification to the FPS Public Health, mandatory for plant-containing supplements.
• Spain, notification to AESAN before sale.
• Portugal, Greece, Romania, Bulgaria, Hungary, Slovakia, each runs its own notification process.
• Germany, Netherlands, Sweden, Denmark, Ireland, generally no pre-market notification, but national maximum levels and label scrutiny apply, and post-market enforcement is real.

National maximum levels per nutrient still vary. France caps several vitamins lower than Italy. The same formula can be compliant in one country and not in the next. Plan country-by-country, not pan-EU.

Maximum levels and forms

The EU is still working toward harmonised maximum levels for vitamins and minerals in food supplements. Until that is done, member states set their own. Use the Annexes of Directive 2002/46 for permitted forms (e.g. magnesium citrate yes, magnesium aspartate no in some interpretations) and consult the national maximum where you are notifying.

Practical compliance routine

1. Build the dossier with the CMO during formulation: spec sheet, formulation rationale, CoAs, label artwork, claims justification.
2. Pre-check every claim against the EU Register.
3. Pre-check every ingredient against the Novel Food Catalogue and the national substance lists.
4. Notify each member state you are selling into, in order of revenue priority. Do not notify all 27 on day one, pick the top 3–5.
5. Keep a regulatory diary. EFSA opinions and Commission regulations publish weekly; subscribe to alerts in your ingredient categories.

Where Jake fits in

Jake is not a regulatory consultant and will not pretend to be. He does pre-vet manufacturers on whether they handle the compliance dossier and notification correctly, which is the difference between a 6-week and a 16-week launch. Tell him your target markets and he will route you to CMOs that already operate compliantly in those countries.